You are here Home Vaccines Vaccines JEspect Details for JEspect vaccine and its components. Listen Print Share Twitter Facebook Email Recently added This page was added on 04 June 2018. Updates made This page was updated on [date-counter-updated-date]. View history of updates Sponsor Seqirus Administration route Intramuscular injection Vaccine group Japanese encephalitis vaccines Description: Registered for use in people aged ≥18 years.Inactivated Japanese encephalitis vaccineEach 0.5 mL monodose pre-filled syringe contains:6 antigen units of purified inactivated Japanese encephalitis virus 0.25 mg aluminium as aluminium hydroxide No preservatives or antibiotics are added.For Product Information and Consumer Medicine Information about JEspect visit the Therapeutic Goods Administration website. Additional vaccine information For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s. Related diseases Japanese encephalitis Page history Last updated 4 June 2018 Last reviewed 4 June 2018 Is there anything wrong with this page? Help us improve the Australian Immunisation Handbook What you were doing? (required) What went wrong? (required) Leave this field blank